Intrinsiqs

Is Iovance Biotherapeutics, Inc. overvalued?

Iovance Biotherapeutics, Inc. (IOVA) — key valuation metrics and fundamentals.

No verdict
Price
$10.99
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$4.91B
Dividend yield
0.0%
Return on equity
-40.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IOVA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.